Financing Cash Flow
Boston Scientific Financing Cash Flow decreased by 76.9% to -$184.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 186.0%, from $214.00M to -$184.00M. Over 4 years (FY 2021 to FY 2025), Financing Cash Flow shows a downward trend with a 42.8% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
cf_net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $6.00M | -$8.00M | -$6.00M | -$344.00M | -$199.00M | $0.00 | -$69.00M | $43.00M | $16.00M | $15.00M | $1.57B | $24.00M | $7.00M | $214.00M | $233.00M | -$340.00M | -$104.00M | -$184.00M |
| QoQ Change | — | +200.0% | -233.3% | +25.0% | <-999% | +42.2% | +100.0% | — | +162.3% | -62.8% | -6.3% | >999% | -98.5% | -70.8% | >999% | +8.9% | -245.9% | +69.4% | -76.9% |
| YoY Change | — | — | — | — | <-999% | <-999% | +100.0% | <-999% | +112.5% | +108.0% | — | >999% | -44.2% | -56.3% | >999% | -85.1% | <-999% | <-999% | -186.0% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Boston Scientific's financing cash flow?
- Boston Scientific (BSX) reported financing cash flow of -$184.00M in Q4 2025.
- How has Boston Scientific's financing cash flow changed year-over-year?
- Boston Scientific's financing cash flow decreased by 186.0% year-over-year, from $214.00M to -$184.00M.
- What is the long-term trend for Boston Scientific's financing cash flow?
- Over 4 years (2021 to 2025), Boston Scientific's financing cash flow has grown at a 42.8% compound annual growth rate (CAGR), from -$95.00M to -$395.00M.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.